検索結果 - David G. Daniel

  • 検索結果 1 - 8 結果 / 8
結果の絞り込み
  1. 1
    Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder A 6-Week Placebo-Controlled Trial

    Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder A 6-Week Placebo-Controlled Trial 著者: David G. Daniel

    出版事項 1999
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    Issues in Selection of Instruments to Measure Negative Symptoms

    Issues in Selection of Instruments to Measure Negative Symptoms 著者: David G. Daniel

    出版事項 2013
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  3. 3
    Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia

    Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia 著者: Daniel E. Casey, David G. Daniel, Adel Wassef, Katherine Tracy, Patricia Wozniak, Kenneth W. Sommerville

    出版事項 2003
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  4. 4
    Methodological Issues in Negative Symptom Trials

    Methodological Issues in Negative Symptom Trials 著者: Stephen R. Marder, David G. Daniel, Larry Alphs, A. George Awad, Richard S.E. Keefe

    出版事項 2011
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophrenia

    The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophrenia 著者: Roger S. McIntyre, David G. Daniel, Eduard Vieta, I. Laszlovszky, Pascal Goetghebeur, Willie Earley, Mehul Patel

    出版事項 2022
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  6. 6
    The Brief Negative Symptom Scale: Psychometric Properties

    The Brief Negative Symptom Scale: Psychometric Properties 著者: Brian Kirkpatrick, Gregory P. Strauss, Linh P. Nguyen, Bernard A. Fischer, David G. Daniel, Angel Cienfuegos, Stephen R. Marder

    出版事項 2010
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data

    Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data 著者: Willie Earley, Hua Guo, David G. Daniel, Henry A. Nasrallah, Suresh Durgam, Yan Zhong, Mehul Patel, Ágota Barabássy, B. Szatmári, György Németh

    出版事項 2018
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia

    Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia 著者: Daniel E. Casey, David G. Daniel, Carol A. Tamminga, John M. Kane, Tram Tran-Johnson, Patricia Wozniak, Walid Abi‐Saab, Jeff Baker, Laura Redden, Nicholas J. Greco, Mario Saltarelli

    出版事項 2008
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: